Red Cell Disorders Collection
 1-5 of 5 Articles
ACP Journal Club |  16 November 2010
Review: Erythropoiesis-stimulating agents targeted to higher hemoglobin levels increase risk for adverse outcomes in CKD
Chi-yuan Hsu, MD, MSc
Ann Intern Med. 2010;153(10):JC5-3. doi:10.7326/0003-4819-153-10-201011160-02003
ACP Journal Club |  20 April 2010
Male gender, diabetes, COPD, anemia, and creatinine clearance < 30 mL/min predicted hospitalization after heart failure diagnosis
Bertram Pitt, MD
Ann Intern Med. 2010;152(8):JC4-2. doi:10.7326/0003-4819-152-8-201004200-02002
ACP Journal Club |  16 March 2010
Darbepoetin decreased transfusions and fatigue, but increased adverse effects in patients with chronic kidney disease, diabetes, and anemia
Tejas V. Patel, MD, MPH, FACP, FASN
Ann Intern Med. 2010;152(6):JC3-9. doi:10.7326/0003-4819-152-6-201003160-02009
ACP Journal Club |  15 December 2009
Anemia was independently associated with mortality in very old persons
David P. Steensma, MD, FACP
Ann Intern Med. 2009;151(12):JC6-13. doi:10.7326/0003-4819-151-12-200912150-02013
ACP Journal Club |  19 August 2008
Review: Erythropoiesis-stimulating agents increase mortality and venous thromboembolism in cancer-associated anemia
Stephan Thomé, MD
Ann Intern Med. 2008;149(4):JC2-8. doi:10.7326/0003-4819-149-4-200808190-02008
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.